These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9328577

  • 1. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
    Partidos CD, Vohra P, Jones D, Farrar G, Steward MW.
    J Immunol Methods; 1997 Aug 07; 206(1-2):143-51. PubMed ID: 9328577
    [Abstract] [Full Text] [Related]

  • 2. Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes.
    Partidos CD, Vohra P, Anagnostopoulou C, Jones DH, Farrar GH, Steward MW.
    Mol Immunol; 1996 Apr 07; 33(6):485-91. PubMed ID: 8700164
    [Abstract] [Full Text] [Related]

  • 3. Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles.
    Partidos CD, Vohra P, Jones DH, Farrar GH, Steward MW.
    J Immunol Methods; 1996 Sep 09; 195(1-2):135-8. PubMed ID: 8814328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles.
    Partidos CD, Vohra P, Jones DH, Farrar G, Steward MW.
    J Control Release; 1999 Dec 06; 62(3):325-32. PubMed ID: 10528070
    [Abstract] [Full Text] [Related]

  • 6. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
    Moureau C, Vidal PL, Bennasser Y, Moynier M, Nicaise Y, Aussillous M, Barthelemy S, Montagnier L, Bahraoui E.
    Mol Immunol; 2002 Jan 06; 38(8):607-18. PubMed ID: 11792429
    [Abstract] [Full Text] [Related]

  • 7. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
    Frangione-Beebe M, Rose RT, Kaumaya PT, Schwendeman SP.
    J Microencapsul; 2001 Jan 06; 18(5):663-77. PubMed ID: 11508771
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC, Yeh MK, Coombes AG, Davis SS.
    Vaccine; 1999 Feb 12; 17(6):512-29. PubMed ID: 10075157
    [Abstract] [Full Text] [Related]

  • 13. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D, Molavi O, Lutsiak ME, Elamanchili P, Kwon GS, Samuel J.
    J Pharm Pharm Sci; 2007 Feb 12; 10(2):217-30. PubMed ID: 17706180
    [Abstract] [Full Text] [Related]

  • 14. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG, Prado N, Moro E, Fernández-García H, Villalba M, Rodríguez R, Batanero E.
    Clin Exp Allergy; 2008 Mar 12; 38(3):520-8. PubMed ID: 18205856
    [Abstract] [Full Text] [Related]

  • 15. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
    Rajkannan R, Dhanaraju MD, Gopinath D, Selvaraj D, Jayakumar R.
    Vaccine; 2006 Jun 12; 24(24):5149-57. PubMed ID: 16713035
    [Abstract] [Full Text] [Related]

  • 16. Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
    Audran R, Peter K, Dannull J, Men Y, Scandella E, Groettrup M, Gander B, Corradin G.
    Vaccine; 2003 Mar 07; 21(11-12):1250-5. PubMed ID: 12559806
    [Abstract] [Full Text] [Related]

  • 17. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
    Men Y, Gander B, Merkle HP, Corradin G.
    Vaccine; 1996 Oct 07; 14(15):1442-50. PubMed ID: 8994320
    [Abstract] [Full Text] [Related]

  • 18. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses.
    Partidos CD, Delmas A, Steward MW.
    Mol Immunol; 1996 Nov 07; 33(16):1223-9. PubMed ID: 9129158
    [Abstract] [Full Text] [Related]

  • 19. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.
    Nixon DF, Hioe C, Chen PD, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, McGee P, Zamb T, Koff W, Wang CY, O'Hagan D.
    Vaccine; 1996 Nov 07; 14(16):1523-30. PubMed ID: 9014294
    [Abstract] [Full Text] [Related]

  • 20. Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization.
    Hsu SC, Schadeck EB, Delmas A, Shaw M, Steward MW.
    Vaccine; 1996 Aug 07; 14(12):1159-66. PubMed ID: 8911014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.